TwinBeech Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
TwinBeech Capital's NBIX Position: Q3 2026 in Review
TwinBeech Capital opened a new position in Neurocrine Biosciences (NBIX) in Q3 2026: 5,076 shares worth $720K. The stake represents 0.17% of the portfolio and ranks #171 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in NBIX as recently as Q4 2025.
TwinBeech Capital first reported a position in NBIX in Q4 2019 and has held it in 12 quarters since. The position peaked at $21M in Q3 2024. 771 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- TwinBeech Capital held 5,076 shares of Neurocrine Biosciences worth $720K as of Q3 2026.
- Neurocrine Biosciences was a new TwinBeech Capital position in Q3 2026.
- Neurocrine Biosciences made up 0.17% of TwinBeech Capital's portfolio in Q3 2026, its #171 holding.
- TwinBeech Capital first reported a position in Neurocrine Biosciences in Q4 2019 and has held it in 12 quarters since.
- TwinBeech Capital's Neurocrine Biosciences position peaked at $21M in Q3 2024.
- 771 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.